Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

Bibliographic Details
Main Authors:	M. A. Qamar, A. Sauerbier, M. Politis, H. Carr, P. A. Loehrer, K. Ray Chaudhuri
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-02-01
Series:	npj Parkinson's Disease
Online Access:	https://doi.org/10.1038/s41531-023-00464-6

Similar Items

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
by: MA Qamar, et al.
Published: (2017-01-01)

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson's patients.
by: Sotirios Polychronis, et al.
Published: (2019-01-01)

Dopaminergic and non-dopaminergic mechanisms of non-motor symptoms of Parkinson disease
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Dural Arteriovenous Fistula-Associated Reversible Parkinsonism with Presynaptic Dopaminergic Loss
by: Hang Rai Kim, et al.
Published: (2015-09-01)

Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism
by: Taewon Kim, et al.
Published: (2022-09-01)

Differential Loss of Presynaptic Dopaminergic Markers in Parkinsonian Monkeys
by: Diane T. Stephenson Ph.D., et al.
Published: (2007-03-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

Parkinson's disease : non-motor and non-dopaminergic features /
by: Olanow, C. W. (Charles Warren), 1941-, et al.
Published: (2011)

Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01)

Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
by: Androulidakis, A, et al.
Published: (2007)

Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism
by: Whitley W. Aamodt, et al.
Published: (2022-04-01)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
by: Juergen Dukart, et al.
Published: (2017-05-01)

Possible role of lncRNAs in amelioration of Parkinson’s disease symptoms by transplantation of dopaminergic cells
by: A. Amini, et al.
Published: (2024-03-01)

Visualization of dopaminergic midbrain structures in Parkinson’s disease
by: R. R. Bogdanov, et al.
Published: (2017-02-01)

Modulation of flight and feeding behaviours requires presynaptic IP3Rs in dopaminergic neurons
by: Anamika Sharma, et al.
Published: (2020-11-01)

Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson’s disease
by: Jérémy Cousineau, et al.
Published: (2022-06-01)

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease
by: Shigeki Hirano
Published: (2021-04-01)

Endocannabinoid modulation of dopaminergic motor circuits
by: Teresa eMorera-Herreras, et al.
Published: (2012-06-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Dopaminergic modulation of emotional conflict in Parkinson’s disease
by: Vanessa eFleury, et al.
Published: (2014-07-01)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
by: Cristina Miguelez, et al.
Published: (2020-09-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson’s Disease
by: Ioannis Ugo Isaias, et al.
Published: (2016-08-01)

Dopaminergic modulation of the praxis network in Parkinson's disease
by: Eva Matt, et al.
Published: (2019-01-01)

Optogenetic measurement of presynaptic calcium transients using conditional genetically encoded calcium indicator expression in dopaminergic neurons.
by: Carmelo Sgobio, et al.
Published: (2014-01-01)

Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.
by: David Reyes-Corona, et al.
Published: (2017-01-01)

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
by: Kathy Dujardin, et al.
Published: (2020-01-01)

Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease
by: José M.M. Bispo, et al.
Published: (2022-09-01)

Behavioral disturbances in Parkinson's disease patients receiving dopaminergic therapy
by: A. V. Nikitina, et al.
Published: (2017-05-01)

Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
by: Myung Jun Lee, et al.
Published: (2022-03-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
by: Paola Ortelli, et al.
Published: (2018-12-01)

Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication
by: Tinkhauser, G, et al.
Published: (2017)

Dopaminergic agents
by: Cowen, P
Published: (2006)

Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy.
by: Shoji Kawashima, et al.
Published: (2013-01-01)

Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
by: Maria-Joao Ribeiro, et al.
Published: (2020-08-01)

Dopaminergic computations for perceptual decisions
by: Liebana, S, et al.
Published: (2024)

Dopaminergic mechanisms of VNS-induced motor system plasticity
by: Catherine Thorn
Published: (2021-11-01)